JP Morgan Chase
HSTO

JP Morgan Chase’s Histogen Inc. Common Stock HSTO Stock Holding History

JP Morgan Chase’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,571
Closed -$13K – 7186
2022
Q2 		$13K Buy
5,571
+5,399
+3,139% +$19.4K ﹤0.01% 5994
2022
Q1 		$1K Buy
+172
New +$871 ﹤0.01% 6525
2020
Q1 		– Hold
0
– – – 5883
2019
Q4 		– Hold
0
– – – 5988
2018
Q3 		– Sell
-223
Closed -$191K – 5907
2018
Q2 		$191K Sell
223
-147
-40% -$122K ﹤0.01% 4580
2018
Q1 		$435K Buy
370
+342
+1,221% +$378K ﹤0.01% 4074
2017
Q4 		$26K Buy
+28
New +$25.9K ﹤0.01% 5103
2016
Q3 		– Sell
-20
Closed -$8K – 4917
2016
Q2 		$8K Buy
+20
New +$9.8K ﹤0.01% 4382

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

JP Morgan Chase's HSTO Position: Q3 2022 in Review

JP Morgan Chase sold out of Histogen Inc. Common Stock (HSTO) in Q3 2022, closing a stake of 5,571 shares — an estimated $13K sold.

JP Morgan Chase first reported a position in HSTO in Q2 2016 and held it in 6 quarters. The position peaked at $435K in Q1 2018. 13 funds tracked by Wall St. Rank hold HSTO as of Q3 2022.

  • JP Morgan Chase reported no remaining Histogen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Chase sold 5,571 Histogen Inc. Common Stock shares in Q3 2022, an estimated $13K.
  • JP Morgan Chase first reported a position in Histogen Inc. Common Stock in Q2 2016 and held it in 6 quarters.
  • JP Morgan Chase's Histogen Inc. Common Stock position peaked at $435K in Q1 2018.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.